There’s been a wave of high-profile drugs tied to potential safety problems. First it was Vioxx. More recently, it was the diabetes drug Avandia. 

Read the rest of this entry »

It’s easy to feel like your pharmacy benefits manager (PBM) holds all the power over your company’s prescription plan costs. In most cases, they do - and your firm pays through the nose.

Read the rest of this entry »